Key Record Dates
ClinicalTrials.gov Identifier: | NCT05386680 |
---|---|
Brief Title: | Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam (STRENGTH) |
First Submitted : | May 18, 2022 |
First Submitted that Met QC Criteria : | May 18, 2022 |
First Posted : | May 23, 2022 |
Last Update Submitted that Met QC Criteria : | January 17, 2024 |
Last Update Posted : | January 19, 2024 |